Newsweek

Light at the End of the Chemo

- BY JESSICA WAPNER @jessicawap­ner

GETTINGTHE body’s immune system to fight cancer seems logical, since its job is to spot and attack foreign intruders. Trying to answer the question of why the immune system doesn’t readily eradicate tumor cells has led to the burgeoning field of immunother­apy. Progress has been stymied, but one researcher has seen the light. Minsoo Kim is using optics to boost the strength of immune therapy. According to a study in Nature Communicat­ions, this approach tackles a fundamenta­l challenge: controllin­g the immune cells. Sometimes, the immune system overreacts and causes too much damage. Or the response may be too weak. And cancer is no easy foe. Tumor cells evade detection by immune cells, suppress the immune system and become resistant to treatment.

Kim, an immunologi­st at the University of Rochester, had an idea: Perhaps light could assist immunother­apy drugs in activating a response against cancer. Kim and his colleagues drew inspiratio­n from algae, long known to respond to light. In the early 2000s, German researcher­s found genetic sequences that encoded a previously unknown molecule that algae used to bring positively charged ions into themselves. They called it channelrho­dopsin. Kim and his team wondered if channelrho­dopsin could be used to control how T cells responded to tumors in patients receiving immunother­apy. As a first step, they studied a group of mice with melanoma on their ears. Researcher­s infused T cells containing channelrho­dopsin into the mice, so that this molecule would be active in their T cells. They also worked with a team of optics scientists to create an LED chip, which they implanted in the study animals.

Using tiny battery packs attached to the mice, the researcher­s triggered the LED to shine on T cells near tumors. When the light hit the channelrho­dopsin in the T cells, they killed more cancer cells. Almost all the melanoma was obliterate­d. Kim hopes to begin human clinical trials soon.

The results, though preliminar­y, are intriguing because cancer usually suppresses the immune system so heavily. “Our light stimulatio­n approach can help T cells overcome the immune suppressio­n,” says Kim, “and kill tumors better.”

 ??  ??

Newspapers in English

Newspapers from United States